Thuốc thử là hóa chất không thể thiếu của bất kỳ phòng thí nghiệm nào và do đó đóng vai trò quan trọng trong việc đảm bảo kết quả phân tích. Thuốc thử phải phù hợp với mục đích sử dụng.
Trong phòng thí nghiệm, hai loại thuốc thử chính thường được phân biệt: loại thương mại và loại được điều chế trong phòng thí nghiệm. Hai loại thuốc thử này chủ yếu được đề cập riêng trong tài liệu này.
Các khuyến nghị về thời hạn sử dụng của dung dịch thuốc thử được chuẩn bị và sử dụng trong phòng thí nghiệm và được trình bày trong tài liệu này được thiết lập dựa trên dữ liệu khoa học (bao gồm dữ liệu xác nhận thu được từ biểu đồ kiểm soát chất lượng, hướng dẫn, tiêu chuẩn, dược điển, ấn phẩm, v.v.) và trên phân tích. kinh nghiệm và kiến thức về OMCL. Thời gian chuẩn bị, chi phí, chính sách quản lý chất thải bền vững và các mối quan tâm về bảo vệ môi trường cũng được xem xét trong quá trình chuẩn bị các khuyến nghị này.
Các khuyến nghị về thời hạn sử dụng của các dung dịch thuốc thử được cung cấp ở đây sẽ cho phép các phòng thí nghiệm đánh giá liệu một dung dịch nhất định có thể được sử dụng một cách an toàn và đáng tin cậy hay không (với điều kiện là các điều kiện bảo quản tuân thủ các yêu cầu) khi chúng tính đến các yếu tố khác nhau góp phần làm giảm chất lượng của một số thuốc thử (nhiệt độ, tiếp xúc với không khí, độ ẩm).
Tiêu chuẩn GMP WHO cho nghiên cứu quản lý theo thời gian (hold-time study). Xem thêm các tài liệu khác trên kênh của Công ty cổ phần Tư vấn Thiết kế GMP EU
3546-1 Revision 0
February 2007
METHOD 3546
MICROWAVE EXTRACTION
SW-846 is not intended to be an analytical training manual. Therefore, method
procedures are written based on the assumption that they will be performed by analysts who are
formally trained in at least the basic principles of chemical analysis and in the use of the subject
technology.
In addition, SW-846 methods, with the exception of required method use for the analysis
of method-defined parameters, are intended to be guidance methods which contain general
information on how to perform an analytical procedure or technique which a laboratory can use
as a basic starting point for generating its own detailed Standard Operating Procedure (SOP),
either for its own general use or for a specific project application. The performance data
included in this method are for guidance purposes only, and are not intended to be and must
not be used as absolute QC acceptance criteria for purposes of laboratory accreditation.
1.0 SCOPE AND APPLICATION
1.1 This method is a procedure for extracting water insoluble or slightly water soluble
organic compounds from soils, clays, sediments, sludges, and solid wastes. This method was
developed and validated on commercially-available solvent extraction systems. Its procedure
uses microwave energy to produce elevated temperature and pressure conditions (i.e., 100 -
115 EC and 50 - 175 psi) in a closed vessel containing the sample and organic solvent(s) to
achieve analyte recoveries equivalent to those from Soxhlet extraction (Method 3540), using
less solvent and taking significantly less time than the Soxhlet procedure. Other systems and
other types of vessels may be used, provided that the analyst demonstrates appropriate
performance for the specific application.
1.2 This method is applicable to the extraction of semivolatile organic compounds,
organophosphorus pesticides, organochlorine pesticides, chlorinated herbicides, phenoxyacid
herbicides, substituted phenols, PCBs, and PCDDs/PCDFs, which may then be analyzed by a
variety of chromatographic procedures. This method may also be applicable for the extraction
of additional target analytes, provided that the analyst demonstrates adequate performance for
the intended application (see Method 3500 and Chapter Two).
1.3 This method has been validated for solid matrices containing from 50 to 10,000
µg/kg of semivolatile organic compounds, 250 to 2,500 µg/kg of organophosphorus pesticides,
10 to 5,000 µg/kg of organochlorine pesticides and chlorinated herbicides, 50 to 2,500 µg/kg of
substituted phenols, 100 to 5,000 µg/kg of phenoxyacid herbicides, 1 to 5,000 µg/kg of PCBs,
and 10 to 6000 ng/kg of PCDDs/PCDFs.
This method may be applicable to samples containing these analytes at higher
concentrations and may be employed after adequate performance is demonstrated for the
concentrations of interest (see Method 3500). It may also be applicable to classes of analytes,
to fuel types, and to ...
Tiêu chuẩn GMP WHO cho nghiên cứu quản lý theo thời gian (hold-time study). Xem thêm các tài liệu khác trên kênh của Công ty cổ phần Tư vấn Thiết kế GMP EU
3546-1 Revision 0
February 2007
METHOD 3546
MICROWAVE EXTRACTION
SW-846 is not intended to be an analytical training manual. Therefore, method
procedures are written based on the assumption that they will be performed by analysts who are
formally trained in at least the basic principles of chemical analysis and in the use of the subject
technology.
In addition, SW-846 methods, with the exception of required method use for the analysis
of method-defined parameters, are intended to be guidance methods which contain general
information on how to perform an analytical procedure or technique which a laboratory can use
as a basic starting point for generating its own detailed Standard Operating Procedure (SOP),
either for its own general use or for a specific project application. The performance data
included in this method are for guidance purposes only, and are not intended to be and must
not be used as absolute QC acceptance criteria for purposes of laboratory accreditation.
1.0 SCOPE AND APPLICATION
1.1 This method is a procedure for extracting water insoluble or slightly water soluble
organic compounds from soils, clays, sediments, sludges, and solid wastes. This method was
developed and validated on commercially-available solvent extraction systems. Its procedure
uses microwave energy to produce elevated temperature and pressure conditions (i.e., 100 -
115 EC and 50 - 175 psi) in a closed vessel containing the sample and organic solvent(s) to
achieve analyte recoveries equivalent to those from Soxhlet extraction (Method 3540), using
less solvent and taking significantly less time than the Soxhlet procedure. Other systems and
other types of vessels may be used, provided that the analyst demonstrates appropriate
performance for the specific application.
1.2 This method is applicable to the extraction of semivolatile organic compounds,
organophosphorus pesticides, organochlorine pesticides, chlorinated herbicides, phenoxyacid
herbicides, substituted phenols, PCBs, and PCDDs/PCDFs, which may then be analyzed by a
variety of chromatographic procedures. This method may also be applicable for the extraction
of additional target analytes, provided that the analyst demonstrates adequate performance for
the intended application (see Method 3500 and Chapter Two).
1.3 This method has been validated for solid matrices containing from 50 to 10,000
µg/kg of semivolatile organic compounds, 250 to 2,500 µg/kg of organophosphorus pesticides,
10 to 5,000 µg/kg of organochlorine pesticides and chlorinated herbicides, 50 to 2,500 µg/kg of
substituted phenols, 100 to 5,000 µg/kg of phenoxyacid herbicides, 1 to 5,000 µg/kg of PCBs,
and 10 to 6000 ng/kg of PCDDs/PCDFs.
This method may be applicable to samples containing these analytes at higher
concentrations and may be employed after adequate performance is demonstrated for the
concentrations of interest (see Method 3500). It may also be applicable to classes of analytes,
to fuel types, and to ...
Quality Documentation
Documentation Overview
The Quality Manual
Types of Quality Documentation
Quality Documentation
Four Attributes of GMP Documentation
Types of Documents
SOP: Standard Operating Procedure
Examples of SOP Categories
Typical SOPs
Components of an SOP
Control of SOPs
Control of SOPs
Raw Material Specifications
Raw Materials
Raw Materials Example
Product Specifications
Master/Batch Production and
Control Records
Master/Batch Production Records
EBR
Laboratory Records
Equipment Cleaning and Use Logs
Equipment Log Example
Distribution Records
Complaint Files
Document Format
Why All The Documentation
Everything you always wanted to know about good documentation but were afraid someone might tell you
Everything you always wanted to know about good documentation but were afraid someone might tell you
Good Documentation Practices
Everything you always wanted to know about good documentation but were afraid someone might tell you
ENTRIES
ELECTRONIC RECORDS
ELECTRONIC RECORDS (con’t)
ELECTRONIC RECORDS (con’t)
COUGAR Pharmaceuticals
Proprietary Information
Project Name: Magnetic Particle Real Time Stability Protocol
Project Number:1002
Protocol Number: QCSASS-03
Date: 7/16/01 Page: 4 of 9
Originator Approval
Date:
R&D Approval
Date:
QC Approval
Date:
QA Approval
Date:
Regulatory Affairs Approval
Date
TABLE OF CONTENTS
21
Study Overview
2
Materials/Methods
3
3
Data Recording and Analysis
5
4
Interpretation of Results
5
5
Reagent Requirements
6
6
Validity Criteria
6
7
Repeat Testing Criteria
6
8
Failure Investigation
7
9
Appendix B: Stability Study Deviation Log
8
10
APPENDIX B: SUMMARY OF MATERIALS AND METHODS
9
Magnetic Particles for Target Capture Reagent
9
1 Study Overview1.1 Objectives
1.2 The objective of this protocol is to provide stability data to support the dating of the Seradyn Magnetic Particles and dT14 Magnetic Particles used in the manufacture of the Target Capture Reagent in the TMA HIV-1/HCV Assay master kit. These Magnetic Particles are stored for extended periods after manufacture but prior to final reagent formulation. In addition, data will be generated to show the Raw Material/Subassembly stay within specification when stored under the recommended conditions during proposed storage times as defined in the QS or QCS documents.
1.3 Definitions
1.3.1 Component: Global term to identify any labeled reagent, subassembly or raw material.
1.3.2 Raw Material: Component manufactured by outside Vendor that is used in manufacture of a second component.
1.3.3 Real Time Stability Study: Subassemblies are incubated at their proposed long term storage temperature for a period of time exceeding the proposed shelf life of the product by at least 20%.
1.3.4 Subassembly: Intermediates in the manufacturing process of the labeled reagents.
1.4 ...
Documentation with respect to release of finished pharmaceutical productMadhuraNewrekar
Documentation is a crucial part of the quality assurance system and is needed in every aspect of pharmaceutical manufacturing. Important documentation with respect to final product release in pharmaceutical industry is explained in brief.
Specialty gases: essential for research, production & quality controlLinde Gas Benelux
Laboratories all around the world stand or fall by their reputation for accuracy and quality control. Pivotal to this performance is the quality, purity and composition of the spectrum of gases harnessed every day to accomplish laboratory tasks.
Rapid advancements in production processes across all industry sectors, as well as healthcare, have obliged laboratories to keep up with these changes, while remaining flexible and making allowances for future requirements. Against this background, a variety of role-specific specialised laboratory types have emerged, each addressing specific industry needs.
Similar to Recommendations on setting the expiry period for commercial and in-house-prepared reagents used in the laboratories of the OMCL Network.docx
Quality Documentation
Documentation Overview
The Quality Manual
Types of Quality Documentation
Quality Documentation
Four Attributes of GMP Documentation
Types of Documents
SOP: Standard Operating Procedure
Examples of SOP Categories
Typical SOPs
Components of an SOP
Control of SOPs
Control of SOPs
Raw Material Specifications
Raw Materials
Raw Materials Example
Product Specifications
Master/Batch Production and
Control Records
Master/Batch Production Records
EBR
Laboratory Records
Equipment Cleaning and Use Logs
Equipment Log Example
Distribution Records
Complaint Files
Document Format
Why All The Documentation
Everything you always wanted to know about good documentation but were afraid someone might tell you
Everything you always wanted to know about good documentation but were afraid someone might tell you
Good Documentation Practices
Everything you always wanted to know about good documentation but were afraid someone might tell you
ENTRIES
ELECTRONIC RECORDS
ELECTRONIC RECORDS (con’t)
ELECTRONIC RECORDS (con’t)
COUGAR Pharmaceuticals
Proprietary Information
Project Name: Magnetic Particle Real Time Stability Protocol
Project Number:1002
Protocol Number: QCSASS-03
Date: 7/16/01 Page: 4 of 9
Originator Approval
Date:
R&D Approval
Date:
QC Approval
Date:
QA Approval
Date:
Regulatory Affairs Approval
Date
TABLE OF CONTENTS
21
Study Overview
2
Materials/Methods
3
3
Data Recording and Analysis
5
4
Interpretation of Results
5
5
Reagent Requirements
6
6
Validity Criteria
6
7
Repeat Testing Criteria
6
8
Failure Investigation
7
9
Appendix B: Stability Study Deviation Log
8
10
APPENDIX B: SUMMARY OF MATERIALS AND METHODS
9
Magnetic Particles for Target Capture Reagent
9
1 Study Overview1.1 Objectives
1.2 The objective of this protocol is to provide stability data to support the dating of the Seradyn Magnetic Particles and dT14 Magnetic Particles used in the manufacture of the Target Capture Reagent in the TMA HIV-1/HCV Assay master kit. These Magnetic Particles are stored for extended periods after manufacture but prior to final reagent formulation. In addition, data will be generated to show the Raw Material/Subassembly stay within specification when stored under the recommended conditions during proposed storage times as defined in the QS or QCS documents.
1.3 Definitions
1.3.1 Component: Global term to identify any labeled reagent, subassembly or raw material.
1.3.2 Raw Material: Component manufactured by outside Vendor that is used in manufacture of a second component.
1.3.3 Real Time Stability Study: Subassemblies are incubated at their proposed long term storage temperature for a period of time exceeding the proposed shelf life of the product by at least 20%.
1.3.4 Subassembly: Intermediates in the manufacturing process of the labeled reagents.
1.4 ...
Documentation with respect to release of finished pharmaceutical productMadhuraNewrekar
Documentation is a crucial part of the quality assurance system and is needed in every aspect of pharmaceutical manufacturing. Important documentation with respect to final product release in pharmaceutical industry is explained in brief.
Specialty gases: essential for research, production & quality controlLinde Gas Benelux
Laboratories all around the world stand or fall by their reputation for accuracy and quality control. Pivotal to this performance is the quality, purity and composition of the spectrum of gases harnessed every day to accomplish laboratory tasks.
Rapid advancements in production processes across all industry sectors, as well as healthcare, have obliged laboratories to keep up with these changes, while remaining flexible and making allowances for future requirements. Against this background, a variety of role-specific specialised laboratory types have emerged, each addressing specific industry needs.
Similar to Recommendations on setting the expiry period for commercial and in-house-prepared reagents used in the laboratories of the OMCL Network.docx (20)
Danh mục 37 thuốc sản xuất trong nước được cấp giấy phép lưu hành tại Việt Nam - Đợt 185.
Quyết định được Cục Quản lý Dược Việt Nam ban hành vào tháng 7 năm 2023.
Danh mục 259 thuốc sản xuất trong nước được cấp giấy đăng ký lưu hành tại Việt Nam - Đợt 185.
Danh mục được ban hành bới Cục Quản lý Dược Việt Nam tháng 7 năm 2023.
Ngày 21/06 vừa qua, cục Quản lý Dược vừa ban hành quyết định về việc công bố danh mục thuốc biệt dược gốc - đợt 2 năm 2023.
Ban hành kèm theo quyết định này bao gồm 83 thuốc biệt dược gốc.
Xem thêm các tài liệu khác trên trang của công ty cổ phần Tư vấn thiết kế GMP-EU.
Hướng dẫn thực hành này cung cấp thông tin cho các nhà sản xuất thức ăn có chất sát khuẩn không an toàn do thuốc chuyển sang thức ăn chăn nuôi không chứa thuốc hoặc một loại thức ăn khác. Mục đích của hướng dẫn này:
• “Sản xuất và phân phối thức ăn có chứa thuốc” đề cập đến việc sử dụng thiết bị để sản xuất, chế biến, đóng gói, giữ và phân phối thức ăn.
• “Thức ăn chăn nuôi” được sản xuất có thêm hóa chất bảo quản. Thức ăn cho động vật như vậy có thể được gọi trong hướng dẫn này là “thức ăn có tẩm thuốc” hoặc “thức ăn không có tẩm thuốc”, tùy thuộc vào việc thức ăn đó có được pha chế để chứa một loại thuốc mới dành cho động vật hay không. Để thuận tiện, chúng tôi gọi những loại thuốc mới dành cho động vật này đơn giản là “thuốc”.
• “Thuốc mang theo” đề cập đến sự hiện diện của thuốc trong lô thức ăn chăn nuôi tiếp theo.
• “Ô nhiễm không an toàn”: đề cập đến mức độ nhiễm bẩn, do một loại thuốc được phép sử dụng trong thức ăn chăn nuôi, gây ra rủi ro không thể chấp nhận được đối với sức khỏe con người hoặc động vật.
Nói chung, các tài liệu hướng dẫn của FDA không thiết lập các trách nhiệm có thể thực thi về mặt pháp lý. Thay vào đó nó mô tả Cơ quan về một chủ đề và chỉ nên được xem dưới dạng khuyến nghị, trừ khi các yêu cầu pháp lý hoặc quy định cụ thể được trích dẫn. Việc sử dụng từ nên trong hướng dẫn của Cơ quan có nghĩa là điều gì đó được gợi ý hoặc khuyến nghị, nhưng không bắt buộc.
Xem thêm các tài liệu khác trên trang của công ty cổ phần tư vấn thiết kể GMP EU.
Cục Quản lý Thực phẩm và Dược phẩm Hoa Kỳ đưa ra hướng dẫn cho các nhà sản xuất và phân phối sữa cho trẻ sơ sinh về các yêu cầu ghi nhãn nhất định đối với các sản phẩm này. Hướng dẫn này đặc biệt chú trọng đến số lượng các công thức sữa cho trẻ sơ sinh có bao bì tương tự nhưng khác nhau về thành phần hoặc mục đích sử dụng. Ngày càng nhiều các sản phẩm ghi sai nhãn về hàm lượng chất dinh dưỡng, do vậy hướng dẫn này cung cấp thông tin có thể giúp các nhà sản xuất hiểu và tuân thủ các yêu cầu ghi nhãn liên quan.
Hướng dẫn này không bao gồm đầy đủ tất cả các quy định liên quan đến việc ghi nhãn sữa công thức dành cho trẻ sơ sinh. Vì vậy bạn có thể xem thêm các hướng dẫn khác tại www.fda.gov/FoodGuidances hoặc các tài liệu trên kênh của công ty cổ phần tư vấn thiết kế GMP EU.
Ngày 25/05 vừa qua, Cục quản lý Dược vừa ban hành danh mục 69 thuốc sản xuất trong nước được cấp giấy đăng ký lưu hành tại Việt Nam - Đợt 184.
Theo đó, ban hành kèm theo Quyết định này danh mục 69 thuốc sản xuất trong nước được cấp giấy đăng ký lưu hành tại Việt Nam - Đợt 184, cụ thể:
1. Danh mục 64 thuốc sản xuất trong nước được cấp giấy đăng ký lưu hành tại Việt Nam hiệu lực 05 năm (Phụ lục I kèm theo).
2. Danh mục 05 thuốc sản xuất trong nước được cấp giấy đăng ký lưu hành tại Việt Nam hiệu lực 03 năm (Phụ lục II kèm theo).
Xem thêm các tài liệu khác trên trang của công tư cổ phần tư vấn thiết kế GMP EU.
Ngày 25/05 vừa qua, Cục quản lý Dược đã ban hành quyết định số 352/QĐ-QLD về việc ban hành danh mục 231 thuốc nước ngoài được cấp, gia hạn giấy đăng ký lưu hành tại Việt Nam - Đợt 184.
Theo đề nghị của Trưởng phòng Đăng ký thuốc, Cục Quản lý Dược quyết định:
Ban hành kèm theo Quyết định này danh mục 231 thuốc sản xuất trong nước được cấp giấy đăng ký lưu hành tại Việt Nam - Đợt 184, cụ thể:
1. Danh mục 172 thuốc sản xuất trong nước được gia hạn giấy đăng ký lưu hành hiệu lực 05 năm (Phụ lục I kèm theo).
2. Danh mục 52 thuốc sản xuất trong nước được gia hạn giấy đăng ký lưu hành hiệu lực 03 năm (Phụ lục II kèm theo).
3. Danh mục 07 thuốc sản xuất trong nước được gia hạn đăng ký lưu hành đến 31/12/2025 (Phụ lục III kèm theo).
Xem thêm các tài liệu khác trên trang của công ty cổ phần Tư vấn thiết kế GMP EU.
Ngày 26/05 vừa qua, Cục Quản lý Dược đã ban hành quyết định số 371/QĐ-QLD về việc công bố danh mục thuốc biệt dược gốc Đợt 1 - năm 2023.
Theo đề nghị của Trưởng phòng Đăng ký thuốc - Cục Quản lý Dược, quyết định:
Công bố Danh mục 56 thuốc Biệt dược gốc Đợt 1 - Năm 2023 tại Phụ lục kèm theo Quyết định này.
Xem thêm các tài liệu khác trên trang của công ty cổ phần Tư vấn thiết kế GMP EU.
Ngày 26/05 vừa qua, Cục Quản lý Dược vừa ra quyết định số 370/QĐ-QLD về việc ban hành danh mục 50 thuốc nước ngoài được cấp, gia hạn giấy đăng ký lưu hành tại Việt Nam - Đợt 111 bổ sung.
Theo đề nghị của Trưởng phòng Đăng ký thuốc - Cục Quản lý Dược quyết định:
Ban hành kèm theo Quyết định này danh mục 50 thuốc nước ngoài được cấp, gia hạn giấy đăng ký lưu hành tại Việt Nam - Đợt 111 bổ sung, bao gồm:
1. Danh mục 41 thuốc nước ngoài được cấp giấy đăng ký lưu hành hiệu lực 05 năm - Đợt 111 bổ sung (tại Phụ lục I kèm theo).
2. Danh mục 01 thuốc nước ngoài được cấp giấy đăng ký lưu hành hiệu lực 03 năm - Đợt 111 bổ sung (tại Phụ lục II kèm theo).
3. Danh mục 07 thuốc nước ngoài được gia hạn giấy đăng ký lưu hành hiệu lực 05 năm - Đợt 111 bổ sung (tại Phụ lục III kèm theo).
4. Danh mục 01 thuốc nước ngoài được gia hạn giấy đăng ký lưu hành đến 31/12/2025 - Đợt 111 bổ sung (tại Phụ lục IV kèm theo).
Ngày 24/05 vừa qua, Bộ Y tế vừa ban hành quyết định về việc công bố danh mục thuốc có chứng minh tương đương sinh học đợt 2 - năm 2023.
Theo đề nghị của Trưởng phòng Đăng ký thuốc - Cục quản lý Dược, quyết định:
Công bố Danh mục 28 thuốc có chứng minh tương đương sinh học Đợt 2 - Năm 2023 tại Phụ lục kèm theo Quyết định này.
Xem thêm các tài liệu khác của Công ty cổ phần Tư vấn thiết kế GMP EU.
More from Công ty Cổ phần Tư vấn Thiết kế GMP EU (20)
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...VarunMahajani
Disruption of blood supply to lung alveoli due to blockage of one or more pulmonary blood vessels is called as Pulmonary thromboembolism. In this presentation we will discuss its causes, types and its management in depth.
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
These lecture slides, by Dr Sidra Arshad, offer a quick overview of physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar leads (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfJim Jacob Roy
Cardiac conduction defects can occur due to various causes.
Atrioventricular conduction blocks ( AV blocks ) are classified into 3 types.
This document describes the acute management of AV block.
Prix Galien International 2024 Forum ProgramLevi Shapiro
June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels:
- ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING
- WOMEN’S HEALTH: FERTILITY PRESERVATION
- WHAT’S NEW IN THE TREATMENT OF INFECTIOUS,
ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES?
- ARTIFICIAL INTELLIGENCE AND ETHICS
- GENE THERAPY
- BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE
- ETHICAL CHALLENGES IN LIFE SCIENCES
- Prix Galien International Awards Ceremony
Recommendations on setting the expiry period for commercial and in-house-prepared reagents used in the laboratories of the OMCL Network.docx
1. General European OMCL Network (GEON)
QUALITY MANAGEMENT DOCUMENT
PA/PH/OMCL (21) 60 R2
Recommendations on setting the expiry period for commercial and
in-house-prepared reagents used in the laboratories of the OMCL Network
Full document title
and reference
Recommendations on setting the expiry period for
commercial and in-house-prepared reagents used in the
laboratories of the OMCL Network, PA/PH/OMCL (21) 60 R2
Document type Recommendation Document
Legislative basis Council Directive 2001/83/EC and 2001/82/EC, as amended
Date of first adoption 31 October 2021
Date of original entry
into force
1 January 2022
Date of entry into
force of revised
document
Previous titles/other
references / last valid
version
N/A
2. Custodian
Organisation
The present document was elaborated by the OMCL Network /
EDQM of the Council of Europe
Concerned Network GEON
N.B. This OMCL Quality Management System document is applicable to members of the European OMCL
Network only. Other laboratories might use the document on a voluntary basis. However, please note that the
EDQM cannot treat any questions related to the application of the documents submitted by laboratories other
than the OMCLs of the Network.
3. PA/PH/OMCL (21) 60 R2 - Recommendations on setting the expiry period for reagents used in the laboratories of the OMCL Network
p. 2/15
Table of Contents
Preface...................................................................................................................................3
1. Purpose...........................................................................................................................3
2. Scope ..............................................................................................................................4
3. Reagents (chemicals).....................................................................................................4
3.1. Definitions ...............................................................................................................4
3.2. Establishing shelf life or an expiry date/period for a reagent (ready-to-use) ...........4
3.2.1. Unopened reagent container ............................................................................4
3.2.2. After opening of the reagent container ............................................................5
3.3. Decision tree for establishing the expiry period after opening of the reagent...........6
4. In-house-prepared reagent solutions ............................................................................6
4.1. Quality check...............................................................................................................6
4.2. Recommended expiry periods ....................................................................................6
4.3. Extension of adopted expiry period............................................................................6
5. Labelling and storage .....................................................................................................7
5.1. Examples of annotations for declared storage conditions..........................................7
6. Conclusions.....................................................................................................................7
7. References......................................................................................................................8
Annex 1..................................................................................................................................9
Annex 2................................................................................................................................10
Annex 3. Risk analysis.........................................................................................................14
4. PA/PH/OMCL (21) 60 R2 - Recommendations on setting the expiry period for reagents used in the laboratories of the OMCL Network
p. 3/15
Preface
Reagents are an integral part of any laboratory and as such play a vital role in ensuring the validity of analytical
results. Reagents must be suitable for the intended use. Consideration should be given to the accompanying
documentation and appropriate physico-chemical or biological critical quality attributes for the intended
purpose/s.
In the laboratory, two major types of reagents are generally distinguished: commercial (off-the-shelf, ready-
to-use) and those prepared in the laboratory (in-house reagents) using the former. These two types of
reagents are mainly dealt with separately throughout this document.
It should be noted that the principles of FIFO (First In-First Out) or FEFO (First Expired-First Out) should be
applied when using reagents.
The shelf life for an unopened product or expiry period after first opening is usually set taking into account its
stability, i.e. how long the quality attributes and chemical integrity of the reagent can be maintained for the
intended analytical application. This can be a challenging task because most manufacturers give the shelf life
of the unopened product and do not provide information on how long the reagent is stable once the container
has been opened.
The recommendations for the shelf life of reagent solutions prepared and used in laboratories and presented
in this document were established based on scientific data (including validation data obtained from quality
control charts, guidelines, standards, pharmacopoeias, publications, etc.) and on the analytical experience and
knowledge of OMCLs. Preparation times, costs, sustainable waste management policies and environmental
protection concerns were also considered during the preparation of these recommendations.
This document is based on the laboratory experience of the OMCL Network. Its purpose is to help maintain
the quality of the work carried out in the laboratory on a daily basis and ensure that the results obtained are
valid.
The recommendations on the shelf life of reagent solutions provided herein should allow laboratories to assess
whether a given solution can be used safely and reliably (provided that the storage conditions comply with
requirements) as they take into account various factors that contribute to the degradation of some reagents
(temperature, air exposure, moisture, etc.).
For the purpose of this document, the expiry period of a reagent solution should be understood as the period
of time during which the reagent is stable and can be used for a given type of analysis. It should be noted
that the same reagent may be unfit for use for some purposes because it has expired, but still suitable for
other purposes.
Purchase or preparation of reagents and reagent solutions in quantities (volumes) not adapted to current
needs should be avoided, as unnecessary disposal that does not take into account the possibility of prolonged
use potentially constitutes a direct threat to the environment. Hence, if prolonging the use of a given reagent
solution for specific purposes is safe and does not compromise the results, such prolongation should always
be considered and justified.
1. Purpose
The aim of this document is to describe and, where possible, define how to set expiry periods for reagents
(chemicals) used in the OMCL Network (and to guide OMCLs in applying them).
It is also intended to provide guidance on regulating the use, labelling, storage and expiry periods of reagent
solutions prepared in OMCLs (in-house solutions) for qualitative, semi-quantitative and quantitative purposes.
5. PA/PH/OMCL (21) 60 R2 - Recommendations on setting the expiry period for reagents used in the laboratories of the OMCL Network
p. 4/15
2. Scope
Use of commercial reagents (chemicals) and reagent solutions prepared in OMCLs within the OMCL Network.
Commercial reagents or reagent preparations for immediate use are out of the scope of this document as
they are not stored and are used within the same day.
In addition, solutions for which there is a certificate by which the traceability to NIST or any other primary
etalon can be established are also out of the scope of this document.
3. Reagents (chemicals)
3.1. Definitions
Reagents
Reagents are solids, gases, liquids or solutions of pure chemical or biological substances, organic
solvents and water.
Quality criteria
Quality criteria are assumed to be covered by appropriate internal standard operating procedures (SOPs).
In general, special consideration should be given to the selection, purchase and receipt of reagents and
their storage. The emphasis is on the crucial step of purchasing reagents of an expected quality and, upon
receipt, on inspection and verification of compliance with the previously set specifications. These steps
precede the labelling and storage of the reagents.
Shelf life of the reagent is a set period or a date given by the manufacturer, which can usually be found
on the certificate of analysis (CoA) for that particular reagent. During this period or until that date, it is
expected that the reagent will meet the quality specifications found in the CoA if the storage conditions in
the material safety data sheet (MSDS) or in any other relevant document, like CoA or label, are respected.
Reagent without a shelf life or a retest date
Sometimes a shelf life is not defined by the manufacturer because the reagent is considered to have an
extensive shelf life when stored unopened under the proper conditions, or the manufacturer has no
supporting stability data. As the quality of a reagent may be altered due to use (effect of environmental
conditions), setting an expiry date is highly recommended. This can be done, for example, by carrying out
a risk assessment.
Recommended retest date for an unopened reagent
If it is possible to obtain a new certificate from the manufacturer, the shelf life of an unopened reagent
can be extended until a later date.
Expiry period is a period or a specific date after opening of the reagent during which it is expected to
maintain the appropriate physico-chemical or biological critical quality attributes for the intended purpose,
in spite of any physical and chemical changes that may occur. The MSDS should be used as a guide on
how to store the reagent after opening.
Extension of the expiry period for a reagent
The expiry period can be extended following a retest taking into account the critical quality attributes
contributing to the functional characteristics of the reagent, checked by appropriate means or by scientific
judgement.
3.2. Establishing shelf life or an expiry date/period for a reagent (ready-to-use)
3.2.1. Unopened reagent container
Usually a reagent is delivered with a stated shelf life for the unopened container.
6. PA/PH/OMCL (21) 60 R2 - Recommendations on setting the expiry period for reagents used in the laboratories of the OMCL Network
p. 5/15
Where no information is available from the manufacturer, the shelf life for unopened reagent containers
can be taken to be the date of receipt plus up to 5 years. This is only applicable if the unopened reagent
container is stored under specified conditions found in relevant documents.
3.2.2. After opening of the reagent container
It is necessary to set a rational expiry period in the absence of analytical data on the stability of the product
after opening. This could be achieved by “real-time monitoring” of the reagent after opening by gathering
experimental analytical data on critical parameters, both chemical and physical, during laboratory use.
In addition, possible sources of information on the stability of a particular reagent are:
the CoA or MSDS for the storage conditions and possible instability;
scientific papers;
chemical knowledge about the nature of the reagents;
stability data – additional information from the manufacturer or supplier (e.g. certificates, which
can be found on manufacturers or suppliers website), guidelines, DIN/ISO Standards,
pharmacopoeial texts, etc.
The expiry period after opening should not exceed the shelf life of the unopened reagent container. If it
does, a risk assessment should be done based on the scientific literature and experimental data to show
that use of the reagent after the end of its shelf life does not compromise its safety or the quality of the
measurement results.
Each time a container is opened, the reagent is exposed to various external factors and environmental
conditions that may alter its integrity and affect its quality, which may compromise the validity of the
results.
Reagent properties, storage conditions, handling and the intended use that have to be considered during
the process of establishing the expiry period after opening are:
Purity of the reagent – this property is very important for establishing the expiry period after
opening. In some cases the higher the purity of the reagent, the shorter the expiry period after
opening. For example, sodium chloride p.a. will have a longer expiry period after opening than
supra-pure sodium chloride, because it is rational to expect that supra-pure solids will deteriorate
more quickly and lose their quality attributes. However, the degree of purity needed for the testing
should be commensurate with the intended use of the reagent: it is important to select the quality
grade that will yield satisfactory results.
Temperature – should be kept controlled within the range given by the manufacturer/stated in
the MSDS and/or in internal SOPs.
Humidity – should meet the requirements given by the manufacturer/stated in the MSDS and/or
in internal SOPs.
Light exposure.
Contamination during use of the reagent – each time a reagent is opened, accidental
contamination is possible (switching of bottle caps, placing bottle caps on soiled surfaces,
transferring reagents to other containers, use of pipettes for withdrawal, etc.)
It is important to state that, regardless of the expiry period established for the opened reagent, a visual
inspection/examination should be done before use and if any of the physical properties that can be
determined by visual inspection have changed, the reagent should be discarded.
Suggested expiry periods for reagents after opening or for ready-to-use reagent solutions in the absence
of manufacturers' instructions (e.g. certificates) or official regulations (DIN/ISO Standards,
pharmacopoeial texts) or literature data are presented in Annex 1.
7. PA/PH/OMCL (21) 60 R2 - Recommendations on setting the expiry period for reagents used in the laboratories of the OMCL Network
p. 6/15
3.3. Decision tree for establishing the expiry period after opening of the reagent
The decision tree presented in Annex 3 demonstrates the decision-making process on how to approach
setting the expiry period after opening.
4. In-house-prepared reagent solutions
Preparation of reagent solutions is carried out in accordance with applicable guidelines, compendial
methods (e.g. pharmacopoeial texts), test method specifications and procedures (Common Technical
Documents [CTDs], SOPs).
4.1. Quality check
It is necessary to ensure that a reagent solution has the properties required for the intended analysis.
Before using prepared reagent solutions, it is strongly recommended to:
perform a visual inspection – any reagent should be discarded if there is a change in colour or
opalescence, or if there is any precipitation (unless it is necessary),
perform a pH check before the use of buffer solutions (if applicable),
determine the titre of volumetric solutions (if applicable),
perform a Ph. Eur. sensitivity test for indicators.
Perform any other suitable qualification test specific to the prepared reagents. The environmental aspect
must always be taken into account when deciding to shorten the expiry period and/or dispose of a reagent
solution. A solution that is no longer suitable for a given analytical procedure may still be suitable for
another purpose.
4.2. Recommended expiry periods
Consideration should always be given to expiry periods:
for reagent solutions described in compendial methods (e.g. 2 months for Primary opalescent
suspension in Ph. Eur. chapter 2.2.1);
provided in drug manufacturers' documentation;
for reagent solutions for immediate use given in the test method specification, (e.g. data from
the marketing authorisation dossiers).
If no stability data is available, it is recommended to use the expiry periods provided in Annex 2. The
expiry periods presented in Annexes 1 and 2 were established on the basis of the analytical experience of
OMCLs, method validation, guidelines, scientific publications [1, 4] and chemical knowledge.
OMCLs can also perform an in-house validation study to determine the initial expiry date.
4.3. Extension of adopted expiry period
It may be acceptable to extend the expiry periods provided in this document under the following
conditions:
risk analysis has been performed (see Annex 3);
and/or
test criteria are established, supporting the extension;
an in-house validation study to determine the expiry period has been performed.
8. PA/PH/OMCL (21) 60 R2 - Recommendations on setting the expiry period for reagents used in the laboratories of the OMCL Network
p. 7/15
The extension of the expiry period and the test criteria should be documented according to internal OMCL
procedures.
5. Labelling and storage
General information on labelling and storage requirements for reagents is given in GL Management of
Reagents, PA/PH/OMCL (11) 157 [3]. Whenever possible, reagent labels should state the expiry period for
an opened container.
More specifically, for reagent solutions:
reagent solutions should be stored under conditions appropriate for their chemical properties;
reagent solutions should be stored under the prescribed storage conditions: temperature,
protected from light, protected from moisture;
reagent solutions should be stored in tightly closed containers;
containers must be closed immediately after use;
alkaline solutions should be stored in plastic containers;
flammable liquids should only be stored in small quantities.
5.1. Examples of annotations for declared storage conditions
protect from light
protect from moisture
use tightly sealed containers (e.g. bottles with lip seals)
laboratory cabinets
refrigerator (2 – 8 °C)
freezer (below – 15 °C)
under vacuum
liquid nitrogen storage
6. Conclusions
In this document, general common practices – mainly derived from published literature and real-life experience
– are set out to help OMCL Network members define expiry periods for commercial reagents, ready-to-use
solutions and in-house-prepared reagents.
As shown in Annexes 1 and 2, different expiry periods can be set for the same type of reagent or in-house-
prepared solution depending on their characteristics and purpose.
Most importantly, when setting the expiry date, traceability and quality must be ensured in order to avoid
compromising the final results of the analytical process, meaning the worst-case scenario should be assumed
when setting the expiry period of a reagent after opening.
Under the worst-case scenario, it should not be presumed that the opened reagent can be used after the
expiry date of the unopened reagent unless valid scientific and experimental analytical evidence of its stability
has been provided and a valid risk assessment has been performed.
For in-house-prepared reagent solutions, the expiry period is set mainly taking into account the intended use
of the solution, the purity of the starting reagent, scientific data and any validation data that has been properly
documented and approved.
9. PA/PH/OMCL (21) 60 R2 - Recommendations on setting the expiry period for reagents used in the laboratories of the OMCL Network
p. 8/15
Periodic and pre-use quality checks should be conducted regardless of the previously set expiry period both
for opened reagents and for in-house-prepared reagent solutions.
As there are few relevant studies demonstrating stability after opening or stability after preparation of in-
house reagents, caution is required when setting the expiry period as it may compromise the quality of the
final analytical result.
7. References
1. Nogueira JMF, Serôdio P. Determination of the expiration date of chemical solutions. Accred Qual Assur
2003;8:231-4.
2. Barwick V, editor. Eurachem/CITAC Guide: Guide to quality in analytical chemistry: an aid to
accreditation. 3rd edition. 2016. ISBN 978-0-948926-32-7. Available at: https://www.eurachem.org/
3. GL Management of Reagents PA/PH/OMCL 11 (157), EDQM
4. Clontz, L. Quality control systems for the microbiology laboratory. The key to successful inspections. PDA,
Baltimore, Maryland, USA; Davis Horwood International Publishing, Godalming, Surrey, UK, 2000.
5. Bartel, D. Use and storage of chemicals, reagents, reagent solutions, samples, primary and secondary
standards, and laboratory calibration reagents “The PEI approach” Paul-Ehrlich-Institut.
6. DIN/ISO standards (e.g. DIN ISO EN 11732: Water quality: Determination of ammonium nitrogen
method by flow analysis.)
10. PA/PH/OMCL (21) 60 R2 - Recommendations on setting the expiry period for reagents used in the laboratories of the OMCL Network
p. 9/15
Annex 1.
Suggested expiry periods for reagents after opening or for ready-to-use reagent solutions in the absence of
manufacturers' instructions (e.g. certificates) or official regulations (DIN/ISO standardspharmacopoeial texts) or
literature data.
Reagent / Reagent
solution
Expiry period after
opening
Exceptions Risk analysis
Acid and alkaline solutions
– inorganic, organic
up to 36 months Shorter expiry period of max.
12 months is recommended
for supra-pure and max. 6
months for ultra-pure
solutions after opening
Intake of CO2 or fuming of gases
changing concentration
Ammonia solution up to 6 months Depending on the purity:
supra- and ultra-pure – max.
1 month
Concentration of ammonia
decreases with time
Aqueous salt solutions up to 6 months / Degradation unlikely
Buffer solutions up to 12 months Phosphate buffer – 3
months; ready-to-use buffer
solutions – manufacturer's
CoA and discard if turbid
Degradation possible after
longer storage, especially for
buffers with pH > 6;
Microbiological contamination
Hydrogen peroxide up to 6 months Depending on the purity:
supra- and ultra-pure – max.
1 month
Concentration of hydrogen
peroxide decreases with time
Indicators – organic,
inorganic
up to 36 months
/
Visual examination before use;
avoid oxidants
Ion-pairs – inorganic,
organic
up to 60 months Sodium lauryl sulfonate –
max. 12 months
Possible disintegration,
check with SST
Inorganic reagents –
solids, salts (not
hygroscopic and light-
degradable salts and
oxides)
from 12 to 36 months Shorter expiry period of max.
24 months is recommended
for supra-pure and max. 12
months for ultra-pure solids
after opening
Disintegration unlikely (salts,
oxides);
Contamination and/or cross-
contamination for supra- and
ultra-pure reagents
Inorganic reagents –
solids, salts (hygroscopic
and light-degradable salts
and oxides)
Should not exceed expiry
date of the unopened
containers
Shorter expiry period of max
12 months is recommended
for supra-pure and ultra-pure
solids after opening
Degradation
Liquid media
Culture media
Discard if turbid;
shelf life: up to 6 months
Note special preparations Degradation and sweating
possible, depends greatly on the
chemical composition of the
media
Organic reagents – liquids up to 24 months
/
Degradation possible only after
longer storage
Organic reagents – solids,
acids, bases
up to 36 months Formaldehyde,
Glutaraldehyde,
Trifluoroacetic acid – expiry
period max. 12 months
Degradation and polymerisation
possible
Organic reagents – solids,
salts (hygroscopic and
light-degradable salts and
oxides)
Should not exceed expiry
date of the unopened
containers
Shorter expiry period of max.
12 months is recommended
for supra- and ultra-pure
solids after opening
Disintegration
Organic reagents – -solids,
salts (not hygroscopic and
light-degradable salts and
oxides)
from 12 to 36 months Shorter expiry period of max.
24 months is recommended
for supra-pure and max. 12
months for ultra-pure solids
after opening
Contamination and/or cross-
contamination for supra- and
ultra-pure reagents
Organic solvents from 12 to 36 months Acetone – max. 24 months
and Ethanol – max. 36
months expiry period after
opening; it also depends on
the purity of the reagent: for
sensitive methods like LC-
MS max. 12 months
Degradation or concentration
change due to intake of water
due to humidity
Sera (animal or human
origin)
up to 10 years, stored as
aliquots in air-tight
containers at min. −20°C
Modified sera may have a
shorter shelf life
Sublimation and disintegration or
clotting possible; reduction in
activity possible
REMARKS:
1. Expiry period of the opened container must not exceed the shelf life of the unopened reagent!
2. All proposed periods are based on the experience of OMCLs (exercise performed by OMCLs) and a
document by Detlef Bartel, Paul-Ehrlich-Institut [5].
3. This list is not exhaustive.
11. PA/PH/OMCL (21) 60 R2 - Recommendations on setting the expiry period for reagents used in the laboratories of the OMCL Network
p. 10/15
Annex 2.
Table 1. Suggested expiry periods for in-house-prepared reagent solutions used for physico-chemical tests,
established on the basis of the analytical experience of OMCLs, method validation, guidelines and available
literature [1].
REAGENT SOLUTION WITH AN IMPACT ON A RESULT
REAGENT SOLUTION MAXIMUM EXPIRY PERIOD RISK FACTORS RECOMMENDATIONS
WATER
Water for chromatography (Ph. Eur.
1095503)
(resistivity [25°C] ≥ 18 MΩ/cm)
Water for preparing mobile phases
without buffers
and
Deionised water
(Ph. Eur. 1095508)
(resistivity [25°C] ≥ 18 MΩ/cm)
24 hours after production
High-purity water
rapidly picks up
contaminants
Bacterial
contamination
Visual inspection
Discard if turbid
Use from fresh and
closed containers
SST criteria must be
fulfilled
Water, purified
(Ph. Eur. 04/2018:0008)
(conductivity [25°C] 5.1 µS/cm)
Water for preparing buffers, diluents
(solvents), dissolution media
3-5 days after production
Bacterial
contamination
Water for injections
and
Sterilised water for injections
(Ph. Eur. 04/2017:0169)
(conductivity [25°C] 1.3 µS/cm)
2 months after production
Bacterial
contamination
Visual inspection
Discard if turbid
Use from fresh and
closed containers
MOBILE
PHASES
and
DILUENTS
Pure organic solvent
(aliquot transferred from the original
container)
6 months or original expiry date
(whichever is shorter)
Depletion
Precipitation
Evaporation of organic
phase
Visual inspection
SST criteria must be
fulfilled
Organic solvents + water
(e.g. acetonitrile/water,
methanol/ water)
SST criteria must be
fulfilled
≥ 50% of organic component 6 months
< 50% of organic component 3 months
Organic solvent + buffer or buffers
for HPLC
2 weeks
SST criteria must be
fulfilled
pH check (if applicable)
Organic solvent + acid/base solution
(e.g. phosphoric acid, perchloric
acid, methanesulfonic acid,
trifluoroacetic acid)
3 months
ACID
SOLUTIONS
for pH adjustment 12 months
Degradation
Visual inspection
SST criteria must be
fulfilled
> 0.1 M HCL 7 months [1]
≤ 0.1 M HCL 2 months [1]
> 0.5 M H2SO4 7 months [1]
≤ 0.5 M H2SO4 2 months [1]
Perchloric acid 1 month [1]
ALKALINE
SOLUTIONS
For pH adjustment 6 months
Absorbs CO2
Keep in tightly closed
container
Plastic container only
SST criteria must be
fulfilled
0.2 M - 5 M NaOH 5 months [1]
≤ 0.1 M NaOH 1 month
12. PA/PH/OMCL (21) 60 R2 - Recommendations on setting the expiry period for reagents used in the laboratories of the OMCL Network
p. 11/15
REAGENT SOLUTION WITH AN IMPACT ON A RESULT
REAGENT SOLUTION MAXIMUM EXPIRY PERIOD RISK FACTORS RECOMMENDATIONS
Ammonia
3 months [1]
SALT
SOLUTIONS
iron(II) and silver salt solutions 6 months
Oxidation
Colour change
Visual inspection
SST criteria must be
fulfilled
2 M (NH4)(CH3COO) 5 months [1]
0.1 M NaCl and 5 ppm NaCl 5 months [1]
Microbial growth
0.1 M Na2SO4 and 10 ppm Na2SO4 5 months [1]
VOLUMETRIC
SOLUTIONS
(*)
COMPLEXOMETRY
0.1 M EDTA 7.5 months [1]
Precipitation
After visual check the
titre must be
determined before use
Plastic container only
0.01 M EDTA(**)
2 months [1]
ARGENTOME
TRY
0.1 M AgNO3 7 months [1]
Photochemical
degradation
After visual check the
titre should be
determined before use
Protect from light
0.01 M AgNO (**)
3 5 months [1]
0.1 M NH4SCN 7 months [1]
REDOXOMETRY
0.1 M I2 7.5 months [1]
Volatility
Air-oxidation
processes
After visual check the
titre must be
determined before use
Keep in tightly closed
container
0.1 M Na2S2O3:
prepare at least 2
weeks before use
0.01 M I (**)
2 5 months [1]
0.1 M Na2S2O3 5 months [1]
0.1 M KMnO4 1 month [1]
After visual check the
titre must be
determined before use
Prepare at least 2
weeks before use
Filter before use
*
For all volumetric solutions, after visual check the titre must be determined before use and the Ph. Eur. criteria for accuracy
must be fulfilled.
**
Diluted solutions should be preferably prepared for immediate and single use.
13. PA/PH/OMCL (21) 60 R2 - Recommendations on setting the expiry period for reagents used in the laboratories of the OMCL Network
p. 12/15
REAGENT SOLUTION WITH AN IMPACT ON A RESULT
REAGENT SOLUTION MAXIMUM EXPIRY PERIOD RISK FACTORS RECOMMENDATIONS
NDICATORS
Ferroin 3 years
Perform the sensitivity
test after preparation
and then periodically
(according to Ph. Eur.)
Visual inspection
Protect from light
Phenolphthalein solution 3 years
Phenol red solution 3 years
Methylene blue 3 years
Methylthymol blue mixture 2 years
Methyl red solution 3 years
BUFFER
SOLUTIONS
Visual inspection
pH or conductivity
calibration/verification buffers
(aliquot transferred from the original
container)
3 months or original expiry date
(whichever is shortest)
Absorbs CO2
depending on pH
Keep in tightly closed
containers
Protect from light
Absorbs CO2
depending on pH Visual inspection
Buffer solutions
(others, e.g. ammonium buffer,
acetate buffer)
2 months
Prone to microbial
growth depending on
pH
Keep in tightly closed
containers
Protect from light
Depletion possible
0.01 M and 0.2 M K2HPO4 1 month and 4 months, respectively [1]
Absorbs CO2
depending on pH
Prone to microbial
growth, depending on
pH
Visual inspection
Keep in tightly closed
containers
Protect from light
0.01 M and 1 M KH2PO4 1 month and 4 months, respectively [1]
0.05 and 0.1 M NaH2PO4 5 months [1]
2 M and 0.03 M (NH4)2HPO4 5 months [1]
10% Na2HPO4 1 day [1]
Very unstable Prepare fresh
SDS buffers or
other surfactants
up to 6 months Precipitation
Visual inspection
[0.2% m/v SDS
solution is particularly
prone to precipitation
depending on the
quality of the starting
reagent]
UREA
Urea solution 1 day
Prepare fresh before
use
14. PA/PH/OMCL (21) 60 R2 - Recommendations on setting the expiry period for reagents used in the laboratories of the OMCL Network
p. 13/15
REAGENT SOLUTION WITHOUT AN IMPACT ON A RESULT
REAGENT SOLUTION MAXIMUM EXPIRY PERIOD RISK FACTORS RECOMMENDATIONS
Organic solvents and water used as supplementary solutions (e.g. for flushing columns, cleaning HPLC system)
≥ 50% of organic component 1 year
Precipitation
Visual inspection,
discard if turbid
< 50% of organic component 6 months
Table 2. Suggested expiry periods for in-house solutions, buffers and media used for microbiological tests or
cell cultivation. Established on the basis of analytical experience of OMCLs and available literature [4].
FOR MICROBIOLOGICAL AND CELL-BASED METHODS
REAGENT SOLUTION MAX. EXPIRY PERIOD RECOMMENDATION
Solid or liquid growth media stored in tightly
sealed containers (e.g. screw capped flasks)
6 months*
Below 25°C or 2-8°C depending on the
medium
Solid or liquid growth media stored in unsealed
containers (e.g. bottles with cellulose plug and
aluminium foil)
1 month
BUFFER SOLUTION STORED IN TIGHT CONTAINERS
Solution of 0.2 M potassium dihydrogen
phosphate 6 months Below 25°C
Solution of 0.2 M sodium hydroxide
Buffers prepared from buffer solutions** 1 month Below 25°C
Glucose 6-phosphate solution in various
concentrations 1 year ≤ − 15°C
Nicotinamide adenine dinucleotide phosphate
(NADP) in various concentrations
1 year
≤ − 15°C
Agarose 5% 3 months
RESEARCH ON ANTISEPTICS AND DISINFECTANTS
REAGENT SOLUTION MAX. EXPIRY PERIOD RISK FACTORS/RECOMMENDATION
Neutraliser stored in tightly sealed containers 6 months
Below 25°C or 2-8°C depending on the
composition
Diluent stored in tightly sealed containers 6 months Below 25°C
INTERFERING SUBSTANCE
Bovine albumin 3 g/100 mL 1 month 2-8°C
Bovine albumin + sheep erythrocytes 3 g/100 mL
+ 3 mL/100 mL
1 week
2-8°C
SOLUTIONS TO BE PREPARED IN HARD WATER
Solution A (magnesium chloride and calcium
chloride)
1 month 2-8°C
Solution B (sodium bicarbonate) 1 week 2-8°C
* Growth promotion tests must be performed within three months of the time of use.
** Prepared from sterile solution.
15. PA/PH/OMCL (21) 60 R2 - Recommendations on setting the expiry period for reagents used in the laboratories of the OMCL Network
p. 14/15
Annex 3. Risk analysis
A list of questions supporting the risk analysis of a decision on expiry date extension (can be extended
depending on the intended use) of in-house-prepared reagent solutions (open catalogue):
1. Is the reagent solution used:
a. for quantitative purposes?
b. for qualitative purposes?
c. as an auxiliary reagent?
2. Is the reagent prone to:
a. oxidation?
b. hydrolysis?
c. photo- or other degradation?
d. evaporation?
e. pH change (e.g. as a result of CO2 absorption)?
f. microbial growth?
3. Is the reagent solution stored properly?
4. Is the buffering capacity/ion strength important for the purpose of use?
5. Is the pH of the solution important for the purpose of use?
6. Is the exact concentration of the solution important for the purpose of use?
7. Was the reagent solution prepared in a sterile manner?
8. Is the reagent solution used in a way that preserves sterility?
9. Is sterility important for the intended use?
10. Can the reagent solution attributes be easily verified/controlled before use (e.g. pH check,
osmolality, absorbance)?
11. Will control tests be performed during the use of the reagent solution that will allow its suitability to
be verified?
12. Are the SST criteria fulfilled while the reagent solution is used?
13. Purity of the reagent?
16. PA/PH/OMCL (21) 60 R2 - Recommendations on setting the expiry period for reagents used in the laboratories of the OMCL Network
p. 15/15
Figure 1. Graphical representation of the decision-making process for determining the expiry period of a
reagent after opening.